ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

BSA Approves Six Concepts

July 19, 2013

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997